Furthermore, FOXL2 expression was discovered to be abnormally high in gastric carcinoma and to boost cell proliferation as well as epithelial–mesenchymal transition (EMT)‐induced metastasis in chemoresistant gastric cancer.28, 29. This evidence concerns the gene FOXL2 and gastric cancer.